Advanced Blockchain AG

  • WKN: A0M93V
  • ISIN: DE000A0M93V6
  • Land: Deutschland

Nachricht vom 19.10.2021 | 08:59

Advanced Blockchain AG Has Invested in Obol Technologies

DGAP-News: Advanced Blockchain AG / Key word(s): Cryptocurrency / Blockchain/Expansion
19.10.2021 / 08:59
The issuer is solely responsible for the content of this announcement.

Advanced Blockchain AG (Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6) participated in the Obol Technologies seed financing round with a 6-figure investment. The company invested alongside significant investors including Ethereal Ventures, Acrylic, Coinbase, and several top angel investors within this space.
 

Obol Technologies (https://obol.tech/) is an open-source and permissionless infrastructure protocol made for staking digital assets. Its mission is to serve as the primary coordination layer for trustless and configurable staking on public blockchain networks. Designed to incentivize collaboration at the network operator level, Obol will provide all network participants with a new primitive for trustless and resilient network validation.
 

Obol accomplished this as a Secret Shared Validator (SSV) network that enables the provisioning of trustless infrastructure on the Ethereum Network. This SSV is a joint research and development effort, commissioned by the Ethereum Foundation in conjunction with the Obol founding team.
 

With a focus of producing trustless validation as a permissionless good for public networks, Obol aligns with Advanced Blockchain's mission: to drive forward innovation and advancements within the blockchain industry, ultimately providing users with maximized benefits.
 

This investment will enable Obol to further develop their technology to provide institutions, self-stakers, and pool operators the ability to create their own staking environments. The staking environments will have superior fault tolerance, resiliency, and robustness without the need to integrate multiple providers or deploy complex infrastructure configuration.
 

This will be a positive addition to Advanced Blockchain's existing investment portfolio, with many visible synergies amongst its portfolio companies. 

Further information on Advanced Blockchain AG and its other projects and investments can be found at https://www.advancedblockchain.com/.


 



19.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021